The AoRTAS Study

  • Research type

    Research Study

  • Full title

    Assessment of Risk in Thoracic Aortopathy using 18F-Sodium Fluoride

  • IRAS ID

    247776

  • Contact name

    David Newby

  • Contact email

    d.e.newby@ed.ac.uk

  • Sponsor organisation

    University of Edinburgh

  • ISRCTN Number

    ISRCTN00000000

  • Clinicaltrials.gov Identifier

    NCT00000000

  • Duration of Study in the UK

    2 years, 7 months, 3 days

  • Research summary

    Patients with Marfan or Loeys-Deitz syndrome (connective tissue disorders), Turner Syndrome (loss of an X chromosome) or bicuspid aortic valve (two aortic valve leaflets instead of three) are at high risk of aortic dissection (tearing of the aorta, the main blood vessel carrying blood away from the heart to the body; a serious condition which is commonly fatal.

    Current management involves measuring the width of the aorta repeatedly and undertaking surgery to replace the aorta when it gets too wide. Using the width of the aorta does not perfectly predict the risk for tearing or rupture. It may miss some patients that are at high risk and require surgery as well as meaning some patients receive surgery that are not at likely to rupture or tear.

    We propose using an imaging test called positron emission tomography (PET) using a type of tracer (18F-sodium fluoride) that lets us visualise areas of aortic disease when combined with an MRI or CT. The special scanners are located in the Edinburgh Imaging Facility, QMRI where the research will take place. We plan to include patients who have Marfan/Leoys-Deitz syndrome, Turner syndrome and bicuspid aortic valve (n=20) as well as 20 controls, broadly age/sex matched to the bicuspid aortic valve group. We will expand the number of participants to 40 (adding 20) in the cohort in which PET/MRI and PET/CT appears most promising. We will perform baseline history, examination, blood pressure, blood tests, PET/CT and PET/MRI scans as well as follow up at 12-24 months.

    We believe the pattern and intensity of tracer uptake on PET will help us understand the mechanisms by which devastating tearing or rupture of the aorta occurs. We will look at how tracer on PET is related to aortic width and clinical events.

  • REC name

    South East Scotland REC 02

  • REC reference

    18/SS/0136

  • Date of REC Opinion

    2 Nov 2018

  • REC opinion

    Further Information Favourable Opinion